diethylstilbestrol has been researched along with pd 123319 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grochal, M; Kulig, A; Kunert-Radek, J; Mucha, S; Pawllkowski, M; Stepień, H; Zieliński, K | 1 |
Kunert-Radek, J; Lawnicka, H; Mucha, S; Pawlikowski, M; Ptasinska-Wnuk, D; Stepien, H | 1 |
2 other study(ies) available for diethylstilbestrol and pd 123319
Article | Year |
---|---|
The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: a quantitative evaluation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diethylstilbestrol; Drug Implants; Imidazoles; Losartan; Male; Microcirculation; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred F344; Silicone Elastomers; Tetrazoles | 1996 |
The involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary.
Topics: Animals; Captopril; Cell Proliferation; Diethylstilbestrol; Estrogens; Gene Expression Regulation; Hyperplasia; Imidazoles; Immunohistochemistry; Losartan; Male; Neovascularization, Pathologic; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A | 2012 |